Published in J Thorac Cardiovasc Surg on March 01, 2002
Impact of the lung allocation score on resource utilization after lung transplantation in the United States. J Heart Lung Transplant (2010) 1.67
Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant (2008) 1.41
Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 0.80
QALYs or quackery? The quagmire of quantifying the cost of breathing. J Thorac Cardiovasc Surg (2002) 0.76
An economic evaluation of lung transplantation. J Thorac Cardiovasc Surg (2003) 0.75
Single versus bilateral lung transplantation: do guidelines exist? Thorac Surg Clin (2015) 0.75
Cost-effectiveness of lung transplantation and its evolution: the Portuguese case. Eur J Health Econ (2013) 0.75
Liberal or restrictive transfusion after cardiac surgery. N Engl J Med (2015) 6.69
Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation (2007) 5.31
Cost of stroke in the United Kingdom. Age Ageing (2009) 4.82
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology (2012) 4.70
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet (2013) 4.35
The efficiency frontier approach to economic evaluation of health-care interventions. Health Econ (2010) 3.95
The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail (2002) 3.17
Equity, waiting times, and NHS reforms: retrospective study. BMJ (2009) 2.86
QALYs: the basics. Value Health (2009) 1.99
Trends in long-term mechanical circulatory support for advanced heart failure in the UK. Eur J Heart Fail (2013) 1.57
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures. J Thorac Cardiovasc Surg (2007) 1.45
Coronary collateral circulation: effect on early and midterm outcomes after off-pump coronary artery bypass surgery. Ann Thorac Surg (2008) 1.42
Effect of normothermic cardiopulmonary bypass on renal injury in pediatric cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg (2011) 1.41
Multislice computed tomography coronary angiography in patients admitted with a suspected acute coronary syndrome. Int J Cardiovasc Imaging (2006) 1.39
Income-related inequalities in the prevalence of depression and suicidal behaviour: a 10-year trend following economic crisis. World Psychiatry (2011) 1.39
Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg (2003) 1.39
Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob Agents Chemother (2003) 1.37
Toward a consensus on the QALY. Value Health (2009) 1.30
Cost-effectiveness of stroke unit care followed by early supported discharge. Stroke (2008) 1.25
Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev (2011) 1.12
Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. Ophthalmology (2013) 1.11
Donor cause of death and medium-term survival after heart transplantation: a United Kingdom national study. J Thorac Cardiovasc Surg (2005) 0.94
In search of a corrected prescription drug elasticity estimate: a meta-regression approach. Health Econ (2007) 0.94
A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK. Cost Eff Resour Alloc (2010) 0.93
The effect of diabetes mellitus on patients undergoing coronary surgery: a risk-adjusted analysis. J Thorac Cardiovasc Surg (2006) 0.92
In defence of our research on competition in England's National Health Service. Lancet (2011) 0.92
Monitoring the performance of residents during training in off-pump coronary surgery. J Thorac Cardiovasc Surg (2004) 0.89
Persistence despite action? Measuring the patterns of health inequality in England (1997-2007). Health Policy (2011) 0.87
The importance of cold and warm cardiac ischemia for survival after heart transplantation. Transplantation (2008) 0.87
Stochastic demand, production responses and hospital costs. J Health Econ (2003) 0.87
Myocardial, inflammatory, and stress responses in off-pump coronary artery bypass graft surgery with thoracic epidural anesthesia. Ann Thorac Surg (2009) 0.86
The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg (2009) 0.86
In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. Ann Thorac Surg (2005) 0.86
Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelines. Am J Manag Care (2003) 0.85
Type A aortic dissection: has surgical outcome improved with time? J Thorac Cardiovasc Surg (2008) 0.85
An assessment of the cost of percutaneous pulmonary valve implantation (PPVI) versus surgical pulmonary valve replacement (PVR) in patients with right ventricular outflow tract dysfunction. J Med Econ (2011) 0.83
Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: ten-year follow-up. J Thorac Cardiovasc Surg (2007) 0.83
Is theatre utilization a valid performance indicator for NHS operating theatres? BMC Health Serv Res (2008) 0.83
Randomized comparison between normothermic and hypothermic cardiopulmonary bypass in pediatric open-heart surgery. Ann Thorac Surg (2005) 0.83
Thoracic epidural anesthesia improves early outcomes in patients undergoing off-pump coronary artery bypass surgery: a prospective, randomized, controlled trial. Anesthesiology (2011) 0.82
Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden. J Med Econ (2012) 0.81
Assessing the benefit of accepting a single lung offer now compared with waiting for a subsequent double lung offer. Transplantation (2011) 0.81
A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2006) 0.81
The economics of screening and treatment in type 2 diabetes mellitus. Pharmacoeconomics (2003) 0.81
The level of income appears to have no consistent bearing on pharmaceutical prices across countries. Health Aff (Millwood) (2011) 0.81
A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients. J Heart Lung Transplant (2005) 0.80
Antibacterial effects of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae strains for which MICs are high, in an in vitro pharmacokinetic model. Antimicrob Agents Chemother (2004) 0.80
Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure. Syst Rev (2014) 0.80
Acquiring proficiency in off-pump surgery: traversing the learning curve, reproducibility, and quality control. Ann Thorac Surg (2005) 0.80
Effect of heart transplantation on survival in ambulatory and decompensated heart failure. Transplantation (2008) 0.80
A Comparison of Health Professionals' and Patients' Views of the Importance of Outcomes of Bariatric Surgery. Obes Surg (2016) 0.79
Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition. Transplantation (2015) 0.78
Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma. Histopathology (2014) 0.78
Cost-effectiveness of highly purified omega-3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting. Eur J Heart Fail (2011) 0.78
UK guidelines for referral and assessment of adults for heart transplantation. Heart (2011) 0.78
The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat heart attacks. Health Econ (2009) 0.77
Liberal or Restrictive Transfusion after Cardiac Surgery. N Engl J Med (2015) 0.77
The Effect of Patient-Specific Cerebral Oxygenation Monitoring on Postoperative Cognitive Function: A Multicenter Randomized Controlled Trial. JMIR Res Protoc (2015) 0.77
Stepwise optimization of the procedure for assessment of circulating progenitor cells in patients with myocardial infarction. PLoS One (2012) 0.77
Who needs a heart transplant? Eur Heart J (2006) 0.77
IQWiG methods--a response to two critiques. Health Econ (2010) 0.77
Systemic safety of anti-VEGF drugs: a commentary. Expert Opin Drug Saf (2014) 0.77
Periadventitial human stem cell treatment reduces vein graft intimal thickening in pig vein-into-artery interposition grafts. J Surg Res (2012) 0.76
Pre-existing renal failure doubles 30-day mortality after heart transplantation. J Heart Lung Transplant (2004) 0.76
On-pump coronary surgery with and without cardioplegic arrest: comparison of inflammation, myocardial, cerebral and renal injury and early and late health outcome in a single-centre randomised controlled trial. Eur J Cardiothorac Surg (2010) 0.76
Pharmacodynamics of ceftazidime plus the serine beta-lactamase inhibitor AM-112 against Escherichia coli containing TEM-1 and CTX-M-1 beta-lactamases. Antimicrob Agents Chemother (2004) 0.75
Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? BMC Public Health (2014) 0.75
Normothermic versus hypothermic cardiopulmonary bypass in children undergoing open heart surgery (thermic-2): study protocol for a randomized controlled trial. JMIR Res Protoc (2015) 0.75
Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study. J Heart Lung Transplant (2011) 0.75
Ascending aorta or arch surgery: is previous cardiac surgery a risk factor? Asian Cardiovasc Thorac Ann (2006) 0.75
Publication selection in health policy research: the winner's curse hypothesis. Health Policy (2012) 0.75
Technology diffusion and substitution of medical innovations. Adv Health Econ Health Serv Res (2012) 0.75
Donor cause of death and mid-term survival in lung transplantation. J Heart Lung Transplant (2005) 0.75
Professor Gavin Mooney 1943-2012. Health Econ (2013) 0.75
The European value-pricing game. Expert Rev Pharmacoecon Outcomes Res (2012) 0.75
Trends in adult heart transplantation: a national survey from the United Kingdom Cardiothoracic Transplant Audit 1995-2007. Eur J Cardiothorac Surg (2009) 0.75
More money for medical research. BMJ (2006) 0.75